Product Information
WARFARIN SODIUM 2 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0930 per EA under NDC 51672402803. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 15, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672402803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
WARFARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040301FDA Approved
7/15/1999
TE Code
AB
On Market Since
7/15/1999
Pharmacological Classes
Price Statistics
The NADAC for WARFARIN SODIUM 2 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0930 per EA |
|---|---|
| All-time high | $0.2221 (Feb 11, 2015) |
| All-time low | $0.0748 (Apr 22, 2026) |
| 52-week high | $0.0930 |
| 52-week low | $0.0748 |
| Median price | $0.1109 |
| Average price | $0.1136 |
| Largest weekly change | +65.9% (Sep 17, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Warfarin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin K Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WARFARIN SODIUM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 2 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0930 per EA (NDC 51672402803), effective Sep 30, 2026.
How has the price of WARFARIN SODIUM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for WARFARIN SODIUM 2 MG TABLET has risen 23.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 2 MG TABLET?
Since Nov 28, 2013, the NADAC for WARFARIN SODIUM 2 MG TABLET has ranged from a low of $0.0748 (Apr 22, 2026) to a high of $0.2221 (Feb 11, 2015), with a median of $0.1109 per EA.
Are there cheaper alternatives to WARFARIN SODIUM 2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as WARFARIN SODIUM 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures WARFARIN SODIUM 2 MG TABLET?
WARFARIN SODIUM 2 MG TABLET (NDC 51672402803) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.